Virtue Capital Management »

Alnylam Pharmaceuticals shares owned by Virtue Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Virtue Capital Management from 13F filings

Historical chart of Virtue Capital Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Virtue Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Virtue Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $965k 2.1k 456.00
2018-09-30 $3.6M 41k 87.53
2018-06-30 $1.5M 15k 98.51
2018-03-31 $754k 7.9k 95.88
2017-12-31 $423k 3.3k 126.91

More positions owned by Virtue Capital Management

Spdr Ser Tr 1 3 hgh yield (BIL)
Proshres Ultrasht 20 Plsyr Trsy Etf Pshs Ultsh 20yrs (QQQ)
Fs Credit Opportunities Common Stock (FLTR)
Ft Vest Laddered Deep Buffer Etf Ft Vest Laddered (FTSL)
Ishares Iboxx Invt Gradebond Etf Iboxx Inv Cp Etf (JAAA)
Spdr Portfolio S P 1500 Cmpst St Etf Portfoli S&p1500 (SPY)
Invsc S P 500 Equal Weight Etf S&p500 Eql Wgt (IEF)
Vanguard Ftse Emerging Markets Etf Ftse Emr Mkt Etf (VOO)
Robinhood Mkts Inc Class A Com Cl A (RSP)
Northern Lts Fd Tr Iv (BUYW)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares 0-5 Year Tips Bond Etf 0-5 Yr Tips Etf (ITA)
Main Buywrite Etf Main Buywrite (MELI)

View all positions for Virtue Capital Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals